Synergy Pharmaceuticals Inc (NASDAQ:SGYP) shares were on a 4% cave yesterday on the heels of Express Scripts setting loose its 2018 National Preferred …
On May 12th, Ardelyx Inc (NASDAQ:ARDX) shares plummeted 39%, quite a stark drop. The cause: a disappointing read-out of the first of two …
BTIG analyst Tim Chiang weighed in today on Synergy Pharmaceuticals Inc (NASDAQ:SGYP), after the drug maker reported the achievement of a milestone few biotechnology companies reach—FDA …
As Synergy Pharmaceuticals Inc (NASDAQ:SGYP) prepares to release top-line results from two pivotal Phase 3 IBS-C trials before 2016 ends, BTIG analyst Tim …
Everyone’s favorite troubled biotech giant Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is making the news cycles rumble once again with official talks that the firm’s …
BTIG analyst Tim Chiang dives in on Synergy Pharmaceuticals Inc (NASDAQ:SGYP) after recent meetings with management have bolstered his positivity on the firm’s shares. As …
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) is anticipated to release pivotal Phase 3 top-line results in IBS-C in the fourth-quarter of this year. Ahead of the …
Shares of drug maker Synergy Pharmaceuticals Inc (NASDAQ:SGYP) rose nearly 9% today after the FDA has accepted the company’s plecanatide for review, allowing investors to breathe a …
BTIG analyst Tim Chiang weighed in today with a cautious stance on the “Mega Inversion” deal between Pfizer Inc.(NYSE:PFE) and Allergan PLC (NYSE:AGN), where Pfizer would acquire Allergan …
In a research report issued today, BTIG analyst Tim Chiang reiterated a Buy rating on shares of Synthetic Biologics Inc (NYSEMKT:SYN), with a $5 price …
